What is the history of Granulomatous Mastitis?

Granulomatous mastitis, first described in 1972, is a rare, chronic inflammatory condition of the breast that has evolved from being frequently misdiagnosed as carcinoma or tuberculosis to being recognized as a distinct, likely autoimmune-mediated process. Understanding of granulomatous mastitis has shifted from surgical-first approaches toward complex, multidisciplinary management involving rheumatology and long-term immunosuppression.

When was granulomatous mastitis first identified?

The condition was formally introduced to medical literature in 1972 by Kessler and Wolloch, who identified it as an idiopathic inflammatory disease of the breast. For decades, clinicians struggled to distinguish granulomatous mastitis from breast cancer or infections like tuberculosis, often leading to unnecessary radical mastectomies before diagnostic techniques improved.

How has the understanding of the disease evolved?

Initially, researchers suspected granulomatous mastitis was primarily infectious. However, as clinical data accrued, the medical community shifted its focus toward an autoimmune or inflammatory etiology. Modern research suggests that the condition may involve a localized immune response to extravasated ductal secretions, leading to the characteristic granulomas seen under a microscope.

What are the major milestones in treatment?

The management of granulomatous mastitis has undergone a significant paradigm shift:

• 1970s-1990s: Reliance on wide local excision and surgical debridement, often resulting in poor wound healing.


• 2000s-Present: Integration of corticosteroid therapy and, in refractory cases, steroid-sparing agents like methotrexate to manage granulomatous mastitis without invasive surgery.


• Diagnostic refinement: The use of core needle biopsy has become the gold standard to rule out malignancy and confirm the diagnosis, preventing unnecessary surgery.

How has patient advocacy changed the landscape?

Historically, patients with granulomatous mastitis felt isolated due to the disease's rarity and the physical toll of recurrent lesions. Today, communities like the 74 members on DiseaseMaps.org provide vital peer support, helping to validate patient experiences and bridge the gap between clinical data and the lived reality of chronic breast inflammation.

Next steps

• Consult with a breast specialist or rheumatologist experienced in autoimmune breast conditions.


• Request a core needle biopsy if you have persistent, non-healing breast masses to confirm a diagnosis of granulomatous mastitis.


• Join the community at DiseaseMaps.org to connect with others who understand the diagnostic journey.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD)


• Orphanet: Rare disease database


• Kessler E, Wolloch Y. Granulomatous mastitis: a lesion clinically simulating carcinoma. Am J Clin Pathol. 1972.


• PubMed: Clinical reviews on idiopathic granulomatous mastitis management.